Compounds > pirinixic acid
Page last updated: 2024-08-16

pirinixic acid and mifepristone

pirinixic acid has been researched along with mifepristone in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (75.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Goya, K; Kasayama, S; Kawase, I; Kitamura, T; Kouhara, H; Kurebayashi, S; Saito, H; Sumitani, S; Xu, X; Yamamoto, H1
Bell, DR; Griffin, KJ; Hsu, MH; Johnson, EF; Savas, U1
Beck, KF; Huwiler, A; Mathieson, P; Pavenstädt, H; Pfeilschifter, J; Ren, S; Saleem, MA; Xin, C1

Other Studies

4 other study(ies) available for pirinixic acid and mifepristone

ArticleYear
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Peroxisome proliferator-activated receptor alpha agonists increase nitric oxide synthase expression in vascular endothelial cells.
    Arteriosclerosis, thrombosis, and vascular biology, 2004, Volume: 24, Issue:4

    Topics: Animals; Aorta; Bezafibrate; Cattle; Cells, Cultured; Dactinomycin; Endothelial Cells; Endothelium, Vascular; Enzyme Induction; Fenofibrate; Gene Expression Regulation, Enzymologic; Half-Life; Mifepristone; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Pyrimidines; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Rosiglitazone; Thiazolidinediones; Transcription Factors; Transcription, Genetic; Transfection

2004
Conditional regulation of the human CYP4X1 and CYP4Z1 genes.
    Archives of biochemistry and biophysics, 2005, Apr-15, Volume: 436, Issue:2

    Topics: Animals; Aorta; Breast; Cell Line, Tumor; Cloning, Molecular; COS Cells; Cytochrome P-450 Enzyme System; Cytochrome P450 Family 4; Databases as Topic; Dexamethasone; DNA Restriction Enzymes; DNA, Complementary; Expressed Sequence Tags; Gene Expression Regulation; Humans; Immunoblotting; Isoenzymes; Mifepristone; Polymerase Chain Reaction; Progesterone; Pyrimidines; Receptors, Glucocorticoid; Receptors, Progesterone; Reverse Transcriptase Polymerase Chain Reaction; RNA; RNA, Messenger; Tissue Distribution; Trachea; Transcription, Genetic; Transcriptional Activation

2005
PPARalpha activation upregulates nephrin expression in human embryonic kidney epithelial cells and podocytes by a dual mechanism.
    Biochemical and biophysical research communications, 2005, Dec-30, Volume: 338, Issue:4

    Topics: Bezafibrate; Cells, Cultured; Embryo, Mammalian; Epithelial Cells; Humans; Interleukin-1; Kidney; Membrane Proteins; Mifepristone; Podocytes; PPAR alpha; Promoter Regions, Genetic; Pyrimidines; RNA, Messenger; Transcriptional Activation; Tumor Necrosis Factor-alpha; Up-Regulation

2005